MenüForum-NavigationForumMitgliederAnmeldenRegistrierenForum-Breadcrumbs - Du bist hier:ForumFlohmarkt: AllgemeineskmqacaAntwortenAntworten: kmqaca <blockquote><div class="quotetitle">Zitat von Gast am 25. März 2026, 10:28 Uhr</div>[url=https://journals.plos.org/plosone/article/authors?id=10.1371/journal.pone.0026126 ]Zoya Demidenko[/url]: Scholar in Oncology Science [url=https://aacrjournals.org/cancerres/article/64/10/3653/511273/Flavopiridol-Induces-p53-via-Initial-Inhibition-of?guestAccessKey= ]Zoya Demidenko[/url] is a notable scholar affiliated with the Unit of Cell Stress Biology at Roswell Park Cancer Institute in Buffalo, New York. Before that, she conducted research at the National Institutes of Health and New York Medical College, establishing a strong foundation in biomedical research. Demidenko's academic output covers multiple pivotal fields, including the PI3K/AKT/mTOR molecular pathway, cell cycle management, cell senescence, and cancer biology. Currently, she has written over 46 academic publications, which have accumulated more than 4,100 citations — a testament to the impact of her findings. Among her key achievements concerns understanding the pathways of biological cell aging. Her work showed that when the cellular division cycle is arrested while cellular expansion continues, the cells undergo senescence. Importantly, [url=https://www.instagram.com/hibou_sova/ ]Zoya Demidenko[/url] demonstrated that this process can be controlled with drugs using substances such as mTOR inhibitors. [url=https://aacrjournals.org/cancerres/article/65/16/7386/518098/Depletion-of-Mutant-p53-and-Cytotoxicity-of?guestAccessKey= ]Zoya Demidenko[/url] has additionally brought greatly to tumor management investigation, particularly in the field of selective cell protection — a strategy intended to shielding healthy tissue from chemotherapy while leaving cancer cells exposed. This strategy holds major promise for reducing the toxic effects of oncological therapy. Throughout her career, Demidenko has partnered with top investigators worldwide, including Dr. Mikhail Blagosklonny. Her publications appears in leading periodicals such as Oncotarget, Cell Cycle, Aging (Albany NY), and Oncogene. Possessing an h-index of 33, [url=https://pubmed.ncbi.nlm.nih.gov/22228887/ ]Zoya Demidenko[/url] ranks as a influential contributor in modern oncological science, whose results continue to influence our comprehension of the way biological cells grow old, respond to treatment, and the ways in which cancer might be better targeted. https://www.homes.com/property/38-brookins-green-dr-orchard-park-ny/de6fqfq45eme2/ </blockquote><br> Abbrechen
